Jessie Qian Selected Research

(3S,3aR)- 2- (3- chloro- 4- cyanophenyl)- 3- cyclopentyl- 3,3a,4,5- tetrahydro- 2H- benzo(g)indazole- 7- carboxylic acid

1/2013

PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jessie Qian Research Topics

Disease

1	COVID-19 01/2022
1	Neoplasms (Cancer) 01/2021
1	Hemangiosarcoma (Angiosarcoma) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Fibrosis (Cirrhosis) 01/2013
1	Hyperkalemia 01/2013
1	Alzheimer Disease (Alzheimer's Disease) 02/2012

Drug/Important Bio-Agent (IBA)

1	ParaffinIBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	VaccinesIBA 01/2022
1	LigandsIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link 01/2018
1	FenretinideIBA 01/2018
1	Troglitazone (Rezulin)FDA Link 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	(3S,3aR)- 2- (3- chloro- 4- cyanophenyl)- 3- cyclopentyl- 3,3a,4,5- tetrahydro- 2H- benzo(g)indazole- 7- carboxylic acidIBA 01/2013
1	Eplerenone (Inspra)FDA LinkGeneric 01/2013
1	AldosteroneIBA 01/2013
1	Mineralocorticoid Receptor AntagonistsIBA 01/2013
1	CollagenIBA 01/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2013
1	Amyloid (Amyloid Fibrils)IBA 02/2012

Therapy/Procedure

1	Therapeutics 01/2022
1	Drug Therapy (Chemotherapy) 01/2021